1256 SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
https://www.nature.com/articles/s41586-020-2598-9
1255 Nociceptors protect sickle cell disease mice from vaso-occlusive episodes and chronic organ damage.
https://rupress.org/jem/article-abstract/218/1/e20200065/182184/Nociceptors-protect-sickle-cell-disease-mice-from?redirectedFrom=fulltext
1254 TGF-β suppresses type 2 immunity to cancer.
https://www.nature.com/articles/s41586-020-2836-1
1253 Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
https://science.sciencemag.org/content/370/6515/eabd4585
1252 A large immunological and genomics study of COVID-19 patients reveals excess mutations in the type I IFN pathway.
https://science.sciencemag.org/content/370/6515/eabd4570
1251 Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense.
https://science.sciencemag.org/content/370/6514/eaay8085
1250 A SARS-CoV-2 mouse model is used to study viral responses and the development of vaccine candidates.
https://science.sciencemag.org/content/369/6511/1603
1249 Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
https://www.cell.com/cell/fulltext/S0092-8674(20)30992-2
1248 Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
https://www.cell.com/cell/fulltext/S0092-8674(20)30993-4
1247 The bacterial-derived metabolite inosine enhances cancer immunotherapy in mice.
https://science.sciencemag.org/content/369/6510/1481
|
